News

Avid Bioservices quality vice president Jeff Masten said the rollout of recent facility enhancements, as well as the plans for the next phases, requires timely, accurate and strategic

The businesses form part of Kemira’s ChemSolutions segment, according to Kemira Oyj. As part of the agreement, the shares of Kemira ChemSolutions, the manufacturing site in Tiel, Netherlands

The company’s loading dose formulation of fusidic acid, CEM-102, has an established history of safety and efficacy outside the US. Open-label trial will randomize 50 PJIs patients with

The kit is built by combining the Gibson Assembly Master Mix along with NEB 5-alpha competent E. coli, enabling fragment assembly and cloning in less than two hours.

The center will combine molecular and cell biologists to provide them with genomics and genotypic data for assessment of biological pathways, disease mechanisms and the characterization of healthy

The deal, which is anticipated to complete in January 2013, is subject to certain closing conditions. Bio-Rad life science group president Brad Crutchfield said, "With this acquisition, Bio-Rad

The activities of Teva-Handok business venture are anticipated to begin in few months subsequent to the issuance of approvals by the regulatory bodies. Teva South Korea chairman, business

Efficacy of the monoclonal anti-toxin medication against inhalational anthrax, caused due to Bacillus anthracis, was established in studies conducted in animal models while the safety profile was demonstrated

The only approved pituitary-directed therapy in the US, for the patients who are not suitable for pituitary surgery, addresses the principal mechanism of Cushing’s disease. Novartis Oncology president